Table 2.
All admissions (A) | Subgroup (B) | Subgroup (C) | Significance p-values | |
All patients (n = 1467) | † without sed. (n = 468) | † with sed. (n = 80) | ||
Gender (%) | ||||
female | 55.8 | 57.1 | 61.2 | n.s. |
Age (years) | ||||
Mean (SD) | 60,8 (17.8) | 63.6 (13.3)* | 54.3 (14.4)** | *p = 0.026 |
Range | (19.7–97.7) | (24.6–97.7) | (19.7–81.1) | **P < 0.001. |
Stage on admission (%) | ||||
Rehabilitative | 33.3 | 15.1** | 13.8** | **P < 0.001 |
Preterminal | 44.3 | 42.2 | 43.8 | P = 0.445 |
Terminal | 19.6 | 36.6** | 38.7** | **P < 0.001 |
Final | 2.8 | 6.2* | 3.8* | *P = 0.002 |
Duration of stay (days) | ||||
Mean (SD) | 21.0 (21.5) | 21.1 (23.6) | 21.5 (20.3) | n.s. |
Median | 16 | 14.0 | 15.5 | |
Range | (0 – 233) | (0 – 199) | (1 – 109) | |
Primary cancer site (%) | ||||
Gastrointestinal | 21.6 | 24.4 | 27.2 | n.s. |
Breast | 15.4 | 15.6 | 6.2 | P = 0.06 n.s. |
Lung, bronchus & trachea | 12.8 | 14.9 | 16.0 | n.s. |
Prostate | 8.8 | 5.2 | 3.7 | n.s |
Female genital | 8.6 | 9.7 | 14.8 | n.s. |
Bones, skin & soft tissue | 6.3 | 6.7 | 7.4 | n.s. |
Nervous system | 3.8 | 3.7 | 1.2 | n.s. |
Urinary system | 3.8 | 3.7 | 7.4 | P = 0.085 n.s. |
Oropharynx & hypopharynx | 3.7 | 4.1 | 7.4 | P = 0.085 n.s. |
Lymphoma | 3.5 | 4.3 | 3.7 | n.s. |
Others | 1.2 | 2.1 | 4.9 | n.s. |
Non-cancer diagnosis | 10.5 | 5.6** | 0.0 | P = 0.001 |